- 3.11.2025
- News
Boulder Weekly: BIFF marches on Four picks to make the most of this year’s fest
The Boulder International Film Festival (BIFF) returns for its 21st year, offering a diverse lineup of films that promise to captivate audiences. This year's festival highlights include The Friend, a heartfelt drama featuring Naomi Watts and Bill Murray; The White House Effect, a gripping archival documentary on climate policy; In Waves and War, an exploration of psychedelic therapy for veterans; and One to One: John & Yoko, a deep dive into John Lennon’s final concert. With over 60 films to discover, BIFF continues to celebrate storytelling in all its forms.
- 3.10.2025
- News
The Microdose: New California bills focus on veterans; the State of Psychedelics; Death penalty for dealers?
California is advancing new legislation aimed at supporting veterans and exploring the therapeutic potential of psychedelics. These bills seek to enhance mental health treatment options for veterans by potentially decriminalizing certain psychedelic substances and funding research into their efficacy for conditions like PTSD. Advocacy groups, such as the Heroic Hearts Project, have been instrumental in promoting these initiatives, emphasizing the need for alternative therapies
- 3.10.2025
- News
CBS News: With RFK Jr. in charge, supplement makers see chance to cash in
As Robert F. Kennedy Jr. takes charge of the Department of Health and Human Services, supplement makers see a major opportunity to expand their influence. With his skepticism of pharmaceutical regulation and a push for "health freedom," the industry aims to make bolder claims, secure government subsidies, and loosen FDA oversight. Advocates praise the shift, while critics warn of the risks posed by unproven treatments.
- 3.6.2025
- News
- Press Releases
Press Release: Texas Lawmaker Rep. Cody Harris Introduces Bill to Fund Ibogaine Research for Addiction and Mental Health Treatment
HB 3717, introduced by Rep. Cody Harris and supported by VETS and the Texas Ibogaine Initiative, will fund FDA-approved clinical trials of ibogaine-a potential breakthrough treatment for substance use disorder and other mental health conditions affecting veterans and non-veterans.
- 3.5.2025
- Blog
The Link Between Sleep and Post-Traumatic Stress Disorder, and The Healing Power of Ibogaine
Ibogaine shows promise in breaking the vicious cycle between PTSD and sleep disturbances in veterans by improving sleep quality and alleviating PTSD symptoms, according to emerging research from Stanford Brain Stimulation Lab and VETS data.
- 2.20.2025
- Blog
Rewiring The Warrior Mind: How Mikey Learned to Love Himself Through Psychedelic-Assisted Therapy
A veteran’s journey from surviving to truly living, Mikey McKim’s story reveals how psychedelic-assisted therapy helped him confront deep-seated trauma, rediscover self-love, and embrace a renewed sense of purpose.
- 2.12.2025
- News
Salon: A psychedelic plant from Africa holds promise for addiction and trauma — but it's not for everyone.
Despite being illegal in the U.S., ibogaine popularity is growing. Here's why this shrub can potentially heal
- 2.7.2025
- Blog
A Historic Step Forward: Baylor College of Medicine Launches Psilocybin Study for Veterans with PTSD
This research initiative stems directly from the passage of Texas House Bill 1802 (HB1802), a legislative victory spearheaded by VETS that gained overwhelming bipartisan support in the Texas House and Senate.
- 2.7.2025
- Blog
Heart-Centered Communication: A VETS Workshop for Veterans and Spouses
A powerful protocol for helping veterans and their spouses bring more awareness, honesty, and presence into relationships.
- 2.6.2025
- Blog
2025: A Defining Year for Veteran Healing Through Policy Change
VETS’ comprehensive strategy aimed at expanding access to treatment, educating lawmakers and veterans, and building coalitions to foster systemic change.